Pappis Charles C reported grant involving 6,400 derivative units of ACM Research, Inc. at $0.00 for $0 on Aug 12, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Aug 26, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
6,400Stock Option
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
6,400Direct
Trade date
Aug 12, 2026Grant
Filed
Aug 26, 2026, 9:30 PM ET15-day reporting delay
Accession
0001140361-26-034528Code A · Transaction 103884
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 12, 2026Grant728$0.00$0Trade 103885
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 15 calendar days after the transaction date.

ACMR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ACMR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +19%1w ago +1.4%1d ago +1.4%
Returns since7d −12%30d −1.9%90d180d1y

Footnotes in full

F1: The option will vest and become exercisable immediately prior to the 2027 annual meeting of stockholders of the issuer, subject to continued service through the vesting date. F2: The price per restricted stock unit is based on the average closing market price of the Issuer's common stock for the 30 trading days preceding the grant day. F3: The restricted stock units should be vested immediately prior to the 2027 annual meeting of stockholders of the issuer, subject to continued service.